While WMH may reflect Wallerian degeneration to some degree in advanced stages of late onset AD, tau burden was not associated with greater than expected WMH volume for participant age in adults with Down syndrome across the lifespan, and WMH age inflection preceded later stage tau deposition, suggesting that cerebrovascular biomarkers are upstream of advanced tau pathology. The gene discussed is MAPT; the disease is Alzheimer disease.